ALT vs NTRS · rev $5.0K vs P/E 18, rev $2.69B
Altimmune Inc (ALT) versus Northern Trust Corporation (NTRS) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
Latest reported ALT revenue for 2025-09-30 was $5.0K. Net income was -$60.7M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. ALT currently screens at market cap $527.0M.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
ALT currently screens at market cap $527.0M. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Not investment advice. Open the ALT and NTRS stock pages for the full models.
Not investment advice.